In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

EHRA Summit 2015: March 26 & 27

'Atrial Fibrillation a risk factor or a risk marker for stroke?'

Over the past few years, the EHRA Summit has become one of the association's main milestones.

The Summit is a yearly opportunity for the representatives of Electrophysiology and Cardiac Pacing Working Groups, National Cardiac Societies as well as EHRA Affiliated Cardiac Societies to meet and exchange upcoming initiatives, scientific activities and public awareness projects.

2015's edition takes a new form as the summit will be especially dedicated to strengthening the relations between EHRA and its Affiliated Cardiac Societies.

The 2015 EHRA Summit took place on 26 & 27 March, at the European Heart House, in Sophia-Antipolis, France.

Atrial Fibrillation: a risk factor or a risk marker for stroke?

Day 1: 26th March

 PresentationBrief SummarySpeakersModerators
13:30 Welcome and Presentation of the Board and the different committees   K-H. Kuck  
13:40 Review of EHRA activities 2014   K-H. Kuck
13:55 EHRA EUROPACE - CARDIOSTIM 2015 Highlights   C. Linde
14:00 Agenda and objective of the EHRA Summit   L. Leclercq
14:05 Risk marker or risk factor: what are the differences?   J. Healey

K-H. Kuck & C. Leclercq  

Atrial fibrillation around the world/ continental perspectives and specificities
14:35 Europe   J. Camm S. Zhang & P.Vardas
14:45 North America   D. Packer
14:55 South America Download L. Aguinaga
15:05 Asia Pacific   A. McGavigan
15:15 Round Table   B. Singh, A. Thornton, A. Vincent
15:45 Strokes in AF patients: characteristics, mechanisms & specificities   K-G. Hausler P.Loh & L.Codesis
16:10 Coffee Break      
AF – as a Risk Marker?
16:30 Assert Sub Study  Download M. Brambatti G. Botto & P. Volders
AF – Alternative Risk Factors or Risk Markers
16:50 AF - endothelial changes/ inflammation/ hypercoagulability   G. Lip G. Botto & P. Volders
17:10 CHA2DS2-VASc 1: to anticoagulate or not?   G. Lip
17:25 LA stunning after cardioversion / LA echo   E. Donal
17:40 Round Table   R. Vatasescu, N. Linker, D. Dobrev
The classical hypothesis: AF as risk factor
17:55 AF stasis, clot formation, embolism   J. Camm K. Okumara & C. Leclercq
AF monitoring and stroke
18:15 Trends Study Download T. Glotzer K. Okumara & C. Leclercq
18:35 X pect Download H. Puererfellner
18:45 Crystal AF   J. Brachmann
18:55 Round Table   C. Vincent, A. Vincent, J.Kautzner, X. Vinolas

Day 2: 27th March

 PresentationBrief Summary SpeakersModerators
08:00 ICD shocks: A risk factor or a risk marker for total mortality  Download J. Healey C. Linde
Imaging of the left atrium : useful to predict stroke?
08:50 New insights in echocardiography for LA assessment   E. Donal A. Moya
09:10 MRI and CT techniques for the evaluation of LA   M. Marwan
09:30 Electrophysiological imaging of LA Download D. Shah
09:50 Round Table   B.Fahn, D. Shah
10:05 Does the type and duration of AF matter for the risk of stroke?   G. Boriani
AF a risk factor or a risk marker: does it matter for therapy?
10:55 Anti coagulant / Antithrombotic therapy Download JY. Le Heuzey
11:10 Drugs Download A. Sarkozy
11:25 AF Ablation   T. de Potter
11:40 LAA Occlusion Download K-H. Kuck
11:55 Are treatments to reduce/prevent stroke in AF cost-effective?   F. Levya
12:10 Round Table   L. Mont, J. Carcia, S. Masset
12:30 Closing Remarks   K-H. Kuck